Results 131 to 140 of about 30,345 (207)

Autosomal dominant polycystic kidney disease

, 2013
Stefan Somlo, Vicente E. Torres, Michael J. Caplan   +2 more
openaire   +2 more sources

The Prevalence, Mechanisms, and Clinical Significance of Inferior Vena Cava Compression in Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study Based on TriNetX. [PDF]

Medicina (Kaunas)
Matarneh A, Matarneh B, Akkari A, Sardar S, Salameh O, Verma N, Ghahramani N.   +6 more
europepmc   +1 more source

Overweight and Obesity Are Associated with Lower Renal Blood Flow in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Kidney Blood Press Res
Birznieks CL, Wang W, Steele C, You Z, Gitomer B, Chonchol M, Nowak KL.   +6 more
europepmc   +1 more source

Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis [PDF]

, 2016
Angelique Sao-Mai Do, Beth Vogt, Bruce Berger, Karin Herrmann, Katherine Dell, Linda Lou, Michael Simonson, Pauravi Vasavada, Robert Cunningham, Rupesh Raina   +9 more
core   +1 more source

RETRACTED: Kebede et al. Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease. <i>J. Pers. Med.</i> 2024, <i>14</i>, 936. [PDF]

J Pers Med
Kebede MA, Mengistu YT, Loge BY, Eshetu MA, Shash EP, Wirtu AT, Gemechu JM.   +6 more
europepmc   +1 more source

Quantitative dynamic contrast-enhanced magnetic resonance imaging for renal perfusion measurement in autosomal dominant polycystic kidney disease. [PDF]

Quant Imaging Med Surg
Onuoha EE, Holland MD, Krishnan C, Mrug M, Kim H.   +4 more
europepmc   +1 more source

Effect of tolvaptan on the prognosis of patients with rapidly progressive autosomal dominant polycystic kidney disease: a prospective open-label study. [PDF]

Front Med (Lausanne)
Zhou L, Li W.
europepmc   +1 more source

SAR-Guided Scaffold Innovation of Selective V₂R Antagonists: Therapeutic Frontiers in ADPKD. [PDF]

ACS Med Chem Lett
Shi H, Li Y, Liang SH.
europepmc   +1 more source

Real-World Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Nondiabetic Autosomal-Dominant Polycystic Kidney Disease: Effects on Progression to Dialysis in a TrinetX Cohort. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Chang CH, Kuo YC, Kuan YH, Lim PS, Chung MC, Pan YR, Luo CW, Wu TK.   +7 more
europepmc   +1 more source

Gastric Neuroendocrine Tumor Presenting Atypically in von Hippel-Lindau Disease: A Case Report. [PDF]

J Kidney Cancer VHL
Chang J, Zhang Q, Liu Z, Bai Y, Ji H, Zhang HM.   +5 more
europepmc   +1 more source